Interleukin-20

International Immunopharmacology

Volumn 4, Issue 5, 2004, Pages 627-633

  Xu, Wenfeng ^a  

^a ZYMOGENETICS INC   (United States)

Author keywords

Interleukin 20; Keratinocytes; Psoriasis

Indexed keywords

INTERLEUKIN 20;

AMINO ACID SEQUENCE; CELL PROLIFERATION; IN VITRO STUDY; KERATINOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PSORIASIS; REVIEW; SIGNAL TRANSDUCTION; SKIN;

ANIMALS; FORECASTING; HUMANS; INTERLEUKINS; PHENOTYPE; RECEPTORS, INTERLEUKIN;

EID: 2142662106     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.01.006     Document Type: Review

References (44)

1. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Initerleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:2001;683-765
2. Gallagher G., Dickensheets H., Eskdale J., Izotova L.S., Mirochnitchenko O.V., Peat J.D., et al. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun. 1:2000;442-450
3. Blumberg H., Conklin D., Xu W.F., Grossmann A., Brender T., Carollo S., et al. Interleukin-20: discovery, receptor identification, and role in epidermal function. Cell. 104:2001;9-19
4. Dumoutier L., Louahed J., Renauld J.C. Cloning and characterization of IL-10-related T-cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J. Immunol. 164:2000;1814-1819
5. Jiang H., Lin J.J., Su Z.Z., Goldstein N.I., Fisher P.B. Subtraction hybridization identifies a novel melanoma differentiation associated gene, MDA-7, modulated during human melanoma differentiation, growth and progression. Oncogene. 11:1995;2477-2486
6. Knappe A., Hor S., Wittmann S., Fickenscher H. Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri. J. Virol. 74:2000;3881-3887
7. Dumoutier L., Leemans C., Lejeune D., Kotenko S.V., Renauld J.C. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J. Immunol. 167:2001;3545-3549
8. Ozaki K., Leonard W.J. Cytokine and cytokine receptor pleiotropy and redundancy. J. Biol. Chem. 277:2002;29355-29358
9. Kotenko S.V., Pestka S. Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene. 19:2000;83-92
10. Walter M.R. Structure of interleukine-10/interleukin-10R1 complex, a paradigm for class 2 cytokine activation. Immunol. Res. 26:2002;303-308
11. Pletnev S., Magracheva E., Kozlov S., Tobin G., Kotenko S.V., Wlodawer A., et al. Characterization of the recombinant extracellular domains of human interleukin-20 receptors and their complexes with interleukin-19 and interleukin-20. Biochemistry. 42:2003;12617-12624
12. Parrish-Novak J., Xu W.F., Brender T., Yao L., Jones C., West J., et al. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. J. Biol. Chem. 277:2002;47517-47523
13. Kotenko S.V. The family of IL-10-related cytokines and their receptors: related, but to what extent? Cytokine Growth Factor Rev. 13:2002;223-240
14. Gijbels M.J., HogenEsch H., Blauw B., Roholl P., Zurcher C. Ultrastructure of epidermis of mice with chronic proliferative dermatitis. Ultrastruct. Pathol. 19:1995;107-111
15. Sun T.T., Tseng S.C., Huang A.J., Cooper D., Schermer A., Lynch M.H., et al. Monoclonal studies of mammalian epithelial keratins: a review. Ann. N.Y. Acad. Sci. 455:1985;307-329
16. Castelijns F.A.C.M., Gerritsen M.J., van Vlijmen-Willems I.M., van Erp P.E., van de Kerkhof P.C. The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis. J. Am. Acad. Dermatol. 40:1999;901-909
17. Vassar R., Fuchs E. Transgenic mice provide new insights into the role of TGFα during epidermal development and differentiation. Genes Dev. 5:1991;714-727
18. Guo L., Yu Q.C., Fuchs E. Targetting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO J. 12:1993;973-986
19. Carroll J.M., Crompton T., Seery J.P., Watt F.M. Transgenic mice expressing IFNγ in the epidermis have eczema, hair hypopigmentation, and hair loss. J. Invest. Dermatol. 108:1997;412-422
20. Cook P.W., Riepkorn M., Clegg C.H., Plowman G.D., DeMay J.M., Brown J.R. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J. Clin. Invest. 100:1997;2286-2294
21. Xia Y.P., Li B., Hylton D., Detmar M., Yancopoulos G.F., Rudge J. Transgenic delivery of VEGF to the mouse skin leads to an inflammatory condition resembling human psoriasis. Blood. 102:2003;161-168
22. Rich B.E. IL-20: a new target for the treatment of inflammatory skin disease. Expert Opin. Ther. Targets. 7:2003;165-174
23. Wang Y.C., Li H.H., Chen P.C., Hsue J.H., Yang J.J., Chang M.S. IL-20: promoter analysis and characterization of biological function. Eur. Cytokine Netw. 14:2003;174. [abstract]
24. Sigmundsdottir H., Gudjonsson J.E., Jonsdottir I., Ludviksson B.R., Valdimarsson H. The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease. Clin. Exp. Immunol. 126:2001;365-369
25. Inaoki M., Sato S., Shirasaki F., Mukaida N., Takehara K. The frequency of type 2 CD8+ T cells is increased in peripheral blood from patients with psoriasis vulgaris. J. Clin. Immunol. 23:2003;269-278
26. Wolk K., Kunz S., Asadullah K., Sabat R. Cutting edge: immune cells as sources and targets of the IL-10 family members? J. Immunol. 168:2002;5397-5402
27. Gröne A. Keratinocytes and cytokines. Vet. Immunol. Immunopathol. 88:2002;1-12
28. Last T.J., Hayden P.J., Burnham B., Klausner M. Use of EpiDerm™ as an inflammatory model for preclinical screening. J. Invest. Dermatol. 119:2002;707. [abstract]
29. Lee E., Cardinale I., Wang F., Chamian M.F., Krueger J.G. Interleukin-20 is up-regulated in psoriasis and responds to conventional and novel biologic therapy. J. Invest. Dermatol. 121:2003;0664. [abstract]
30. Rich B.E., Kupper T.S. Cytokines: IL-20 - a new effector in skin inflammation. Curr. Biol. 11:2001;R531-R534
31. Krueger G., Koo J., Lebwohl M., Menter A., Stern R.S., Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch. Dermatol. 137:2001;280-284
32. Prinz J.C. The role of T cells in psoriasis. J. Eur. Acad. Dermatol. Venereol. 17:2003;257-270
33. Goffe B., Cather J.C. Etanercept: an overview. J. Am. Acad. Dermatol. 49:2003;S105-S111. [Suppl.]
34. Gottlieb A.B. Infliximab for psoriasis. J. Am. Acad. Dermatol. 49:2003;S112-S117. [Suppl.]
35. Krueger G.G., Callis K.P. Development and use of alefacept to treat psoriasis. J. Am. Acad. Dermatol. 49:2003;S87-S97. [Suppl.]
36. Leonardi C.L. Efalizumab: an overview. J. Am. Acad. Dermatol. 49:2003;S98-S104. [Suppl.]
37. Kanitakis J., Butnaru A.C., Claudy A. Novel biological immunotherapies for psoriasis. Expert Opin. Investig. Drugs. 12:2003;1111-1121
38. Kupper T.S. Immunologic targets in psoriasis. N. Engl. J. Med. 349:2003;1987-1990
39. Liu L., Ding C., Zeng W., Heuer J.G., Tetreault J.W., Noblitt T.W., et al. Selective enhancement of multipotential hematopoietic progenitors in vitro and in vivo by IL-20. Blood. 102:2003;3206-3209
40. Liu L., Zeng W., Tetreault J., Noblitt T., Hangoc G., Cooper S., et al. IL-20 specifically stimulates the proliferation of human and murine multipotential hematopoietic progenitors. Blood. 100:2002;710. [abstract]
41. Wigle D.A., Jurisica I., Radulovich N., Pintilie M., Rossant J., Liu N. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. Cancer Res. 62:2002;3005-3008
42. Hosoi T., Wada S., Okuma Y., Nomura Y. Lipopolysaccharide induces IL-20 expression in the primary cultured glial cells. Jpn. J. Pharmacol. 88:2002;P-112. [abstract]
43. Oleksyk T.K., Thio C.L., Truelove A.L., Goedert J.J., Donfield S., Thomas D.L., et al. Genetic linkage and association of single nucleotide polymorphisms in the IL10 region and HCV clearance. Am. J. Hum. Genet. 73:2003;1256. [abstract]
44. Asadullah K., Sabat R., Wiese A., Docke W.D., Volk H.D., Sterry W. Interleukine-10 in cutaneous disorders: implications for its pathophysiological importance and therapeutic use. Arch. Dermatol. Res. 291:1999;628-636